Join to View Full Profile
Moffitt Cancer Center12902 Magnolia DriveTampa, FL 33612
Phone+1 813-745-4673
Dr. Veloski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Temple University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2007- Temple University HospitalResidency, Internal Medicine, 1994 - 1997
MCP-Hahnemann College of MedicineClass of 1994
Certifications & Licensure
FL State Medical License 2018 - 2027
PA State Medical License 1995 - 2021
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
Publications & Presentations
PubMed
- Thyroid Paraganglioma: A Rare Manifestation of Paraganglioma Syndrome Associated With Pathogenic Variant in.Valentina D Tarasova, Kelara Samuel, Caitlin McMullen, Sergiy Kushchayev, Juan C Hernandez Prera
JCEM Case Reports. 2024-09-01 - Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.Zachary A Hurst, Sandya Liyanarachchi, Pamela Brock, Huiling He, Fadi Nabhan
Thyroid. 2024-03-01 - 5 citationsCharacterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.Valentina D Tarasova, Jill Tsai, Jude Masannat, Juan C Hernandez Prera, Julie Hallanger Johnson
Thyroid. 2024-02-01
Authored Content
- Endocrine-related adverse events associated with immune checkpointblockade and expert insights on their management7/1/2017
- Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.5/16/2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
